CWBR Cohbar Inc.

CohBar Inc is a research stage biotechnology company. The Company conducts investigational research into Mitochondrial-Derived Peptides to evaluate their therapeutic potential through in vitro and in vivo models.

$0.20
As of 05/27/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/28/2015
Outstanding shares:  86,981,684
Average volume:  550,448
Market cap:   $15,343,569
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.71
PS ratio:   0.00
Return on equity:   -119.04%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy